Abstract
Purpose
Methods
Results
Conclusion
Notes
Data availability
Data files are available from Harvard Dataverse: https://doi.org/10.7910/DVN/TYWWZ2
Dataset 1. Data file containing the study design and guidelines of articles published from 2021 to September 2022 in the Journal of Educational Evaluation for Health Professions.
Supplementary materials
Notes
Editor’s note
There are many study designs in the Equator network (https://www.equator-network.org/) and the United States National Library of Medicine Research Reporting Guidelines and Initiatives (https://www.nlm.nih.gov/services/research_report_guide.html). I recommended descriptions that I believed were reasonable for each manuscript and corresponding reporting guideline in the Methods section. I should confirm whether my recommended description is suitable. The most critical point is that there are no suitable reporting guidelines for descriptive studies and before-and-after studies. For a while, I recommended that authors describe their work as cross-sectional observational studies instead of descriptive studies and suggested that the authors write the manuscript according to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement. I frequently suggested that authors re-describe the study design and corresponding reporting guidelines. Therefore, those descriptions in JEEHP do not solely reflect the authors’ opinions. It is time to evaluate my trial attempt to recommend that authors provide a written description of the study design and corresponding reporting guidelines. I invited Dr. Soo Young Kim, an expert in this field, to check whether the study designs and corresponding reporting guidelines were suitable. He is the author of the “study design algorithm for medical literature on interventions” (DAMI) classification. In the present study, he indicated that some study designs and reporting guidelines should be re-classified as more suitable ones. I will follow his opinion. However, since there are no suitable reporting guidelines for descriptive studies, I will continue using the STROBE statement for these studies. Furthermore, I eagerly anticipate the development of reporting guidelines for descriptive studies by an expert group.
References
Table 1.
Table 2.
Table 3.
STARD, Standards for the Reporting of Diagnostic Accuracy Studies; TREND, Transparent Reporting of Evaluations with Nonrandomized Designs; PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses; PRISMA-ScR, PRISMA-scoping reviews; STROBE, Strengthening the Reporting of Observational Studies in Epidemiology; CONSORT, Consolidated Standards of Reporting Trials; COREQ, Consolidated Criteria for Reporting Qualitative Research.
Table 4.
Study design | No. (%) |
---|---|
Descriptive cross-sectional survey | 14 (51.9) |
Before-and-after study | 9 (33.3) |
Narrative review | 3 (11.1) |
Technical report | 1 (3.7) |
Total | 27 (100.0) |